Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.18209 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Adalet Altunsoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Health Science, Ankara City Hospital, Infectious Diseases and Clinical Microbiology. Ankara, Turkey. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Prostate, Anti-Bacterial Agents, Bacteremia. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study aims to show the bacteriologic picture of acute prostatitis and bacteremia caused by infective agent after transrectal ultrasound-guided prostate biopsy (TRUSBx) and to determine the resistance rates of the infections in patients undergoing transrectal biopsy and to guide prophylaxis approach before biopsy. Methodology: The retrospective data of 935 patients who underwent TRUSBx between January 2010 to January 2019 were reviewed. Pre-biopsy urine cultures and antimicrobial susceptibility were obtained. Subsequently, patients admitted to the hospital with any complaint after biopsy were examined for severe infection complications.
Results
Of the 430 (61.7%) patients who underwent urine culture before the procedure, 45 (10.5%) had growth; 30 (66.7%) of the growing microorganisms were Escherichia coli. Twenty (44.4%) of all Gram-negative agents in pre-biopsy urine culture were susceptible to quinolone. Post TRUSBx bacteremia was present in 18.2%, urinary system infection in 83.6%, and hospitalization in 61.8% of 55 patients who were admitted to the hospital. In the isolated gram-negative microorganisms, fluoroquinolones resistance in urinary system infections was seen in 40% and bacteremia was seen in 70% of the cases. ESBL-producing Gram-negative bacteria were determined in 40% of infections in blood and 38.5% of urinary system infections in the post biopsy period in the current study.
Conclusions
These high antibiotic resistance rates suggest that we better review our pre-procedure prophylaxis approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Health Science, Ankara City Hospital, Infectious Diseases and Clinical Microbiology. Ankara, Turkey.
- Department of Urology, University of Health Sciences, School of Medicine, Ankara City Hospital, Ankara, Turkey.
- Ankara City Hospital, Infectious Diseases and Clinical Microbiology. Ankara, Turkey.
- Department of Urology, Koç University Hospital, İstanbul, Turkey.
Zitieren
APA
Altunsoy, A., Coşer, Ş., Kemirtlek, N., Aykanat, I. C., Balci, M., Bodur, H., & Tuncel, A. (2024). Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18209
Vancouver
Altunsoy A, Coşer Ş, Kemirtlek N, Aykanat IC, Balci M, Bodur H, et al. Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.18209
BibTeX
@article{Altunsoy2024,
author = {Altunsoy, Adalet and Coşer, Şeref and Kemirtlek, Nizamettin and Aykanat, Ibrahim Can and Balci, Melih and Bodur, Hürrem and Tuncel, Altuğ},
title = {Should we review our prophylaxis approach for increased antibiotic resistance in transrectal prostate biopsy?},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.18209}
}
EUVIMED